Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METEORA-II: VEX vs Paclitaxel in Advanced Breast Cancer
NCT02954055Phase 2Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Start
- Sep 2017
- Primary completion
- Nov 2021
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, cyclophosphamide, capecitabine in breast cancer, sponsored by ETOP IBCSG Partners Foundation. Started Sep 2017; status: completed.
02
Drugs
vinorelbinecyclophosphamidecapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02954055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02954055.